Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
OM Pharma Ltd. is seeking a Regulatory Affairs Lead to drive Swiss regulatory strategy and lifecycle management for its Swiss portfolio.
Based in Villars-sur-Glâne, you will lead a Regulatory Specialist and collaborate with cross-functional teams to ensure compliance across development and product lifecycle. The role demands a university life sciences degree, 5+ years in Regulatory Affairs, and fluency in English with French or German.
Location: Villars-sur-Glâne, Fribourg, CH
Division: Regulatory Affairs
Job Type: Permanent role
Take the lead in regulatory affairs for OM Pharma’s Swiss portfolio, including partner products. Combining strategic ownership with hands-on delivery, you will manage a Regulatory Specialist and work closely with cross-functional teams to ensure regulatory compliance throughout the product lifecycle. Based in Villars-sur-Glâne, you will report to the Head of Market Access & External Affairs, Swiss Affiliate.
Your key responsibilities are as follows:
What you bring:
You combine sound regulatory judgement with a pragmatic, hands-on and business-oriented approach. Autonomous and well-organised, you balance competing priorities without compromising quality or compliance. You build effective relationships, communicate clearly and influence stakeholders constructively. As a supportive team leader, you provide clear direction and foster collaboration and continuous improvement.
OM Pharma is a global Geneva-based biopharmaceutical company. It is a leader in the prevention of recurrent respiratory and urinary tract infections and is also active in the treatment of vascular diseases.
It operates worldwide through a strong network of international partners and invests its profits in R&D to develop microbial derived immunotherapeutic products to treat acute and chronic immunological disorders resulting from inflammation and infections.
The company strives to improve the quality of life of patients around the world by providing access to better treatment of immunological imbalances.